Vaccine makers are pushing the European Union for certain liability protections, The Financial Times reports. This would include a "comprehensive no-fault and non-adversarial compensation system, and an exemption from civil liability" if there are problems with the Covid-19 vaccines, "in order to compensate for such high risks taken by manufacturers." Last month, AstraZeneca ( AZN ) secured partial exemption from future product liability claims on its vaccine candidate, which it is developing in partnership with the University of Oxford.